Net profit of Sandu Pharmaceuticals rose 4.00% to Rs 0.52 crore in the quarter ended September 2025 as against Rs 0.50 crore during the previous quarter ended September 2024. Sales declined 0.45% to Rs 17.62 crore in the quarter ended September 2025 as against Rs 17.70 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales17.6217.70 0 OPM %4.885.14 - PBDT0.880.91 -3 PBT0.710.74 -4 NP0.520.50 4 Powered by Capital Market - Live News

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 October 2025.Powered by Capital Market - Live News

Sandu Pharmaceuticals announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live News

Net profit of Sandu Pharmaceuticals rose 29.41% to Rs 0.22 crore in the quarter ended June 2025 as against Rs 0.17 crore during the previous quarter ended June 2024. Sales declined 2.05% to Rs 16.70 crore in the quarter ended June 2025 as against Rs 17.05 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales16.7017.05 -2 OPM %3.172.46 - PBDT0.520.44 18 PBT0.340.28 21 NP0.220.17 29 Powered by Capital Market - Live News